Research funder · United States

Michael J. Fox Foundation for Parkinson's Research

Non-profit organization in the USA

michaeljfox.org

Grants since 2016: 1 275
Awarded, last 5 years (where amounts are published): —
Funded works, last 5 years: 3 085
Funded works, all time: 6 716

Grants

2026 · research · Research Grant

Validation of ADx LRRK2 and pS1292 LRRK2 SiMOA Assays Using Standardized Sample Set

Erik Stoops · ADx NeuroSciences

2026 · research · ASAP CRN Discovery Fellowship 2025

Unravelling the Impact of the Microbiome on Motor Dysfunction in Parkinson’s Disease Using Phenotypic Heterogeneity in the Pink1-/- Infection-Induced Disease Model

Alexandra Kazanova

2026 · research · ASAP CRN Discovery Fellowship 2025

Does Pathogenic α-Synuclein Disrupt Lipid Droplet–Mitochondria Coupling in Parkinson’s Disease?

Mukesh Kumar

2026 · research · Summer 2025 RFA: Personalized Approaches for Understanding, Assessing and Improving Gait in Parkinson’s Disease Research Program

A Novel Digital Music-based Autonomous Personalized Walking Intervention to Improve Gait and Walking Automaticity in Parkinson Disease

Terry Ellis · Boston University

2026 · research · Research Grant

Automated Platform for Standardizing and Validating GBA1 Human iPSC Models To Accelerate Mechanistic and Therapeutic Discovery in Parkinson’s Disease

Stefan Semrau · Jax-nyscf

2026 · research · ASAP CRN 2025 RFA Scientific Track

Defining Separate Rewarding and Aversive Dopaminergic Circuits and Their Role in Parkinson's Disease Associated Pain

Rajeshwar Awatramani · Northwestern University

2026 · research · Spring 2025 RFP: Accelerating Biological Understanding and Therapeutic Translation for PD- Biology

Bidirectional Genome-wide CRISPRi/a Screening Using Ratiometric GCase Substrates to Identify Genetic Modulators of Lysosomal GCase Activity

David Vocadlo · Simon Fraser University

2026 · research · ASAP CRN 2025 RFA Scientific Track

Deciphering the Aggregatome: Unraveling Alpha-Synuclein Seeding Drivers in Parkinson’s Disease Across Human Biomaterials

Matthias Mann · Max Planck Institute of Biochemistry

2026 · research · The Bridge Initiative - Supplement: Parkin peptide binders characterization - powder reconfirm and structures

The Bridge Initiative

Kalle Gehring · McGill University

2026 · research · ASAP CRN Discovery Fellowship 2025

Network Control of Neuronal Resilience in Parkinson’s Disease

J. Kate Brynildsen

2026 · research · Research Grant

Genetically Encoded Fluorescent Biosensors for Live-cell, Subcellular Detection of Distinct α-synuclein Aggregation States

Loren Looger · University of California San Diego

2026 · research · Research Grant

Including a Watch to the Gait Substudy

Anat Mirelman · Aviv University

2026 · research · Spring 2025 RFA: Molecular MRI Biomarker Program

Development of Next Generation Metabolic MR Imaging to Probe Molecular Mechanisms and Treatment Response in PD Patients Across Disease Stages

Ovidiu C. Andronesi · Massachusetts General Hospital

2026 · research · Fall 2025 RFP: Data Advice To Action

Identifying Blood-Based Proteomic Biomarkers of Cognitive Decline and its Pathological Heterogeneity in PD and DLB

Nicholas T. Seyfried · Emory University

2026 · research · ASAP CRN 2025 RFA Scientific Track

Aging and the Heterogeneity of Parkison’s Disease – The Role of Heterochromatin Erosion

Roger Barker · University of Cambridge

2026 · research · Spring 2025 RFA: Molecular MRI Biomarker Program

Exploring Dynamic Brain Metabolism in PD

Duan Xu · University of California, San Francisco

2026 · research · Parkinson’s Disease Therapeutics Pipeline Program -Pre-Clinical

CSM-101 TRPML1 Agonist for Parkinson’s Disease

Leon Murphy · Casma Therapeutics (United States)

2026 · research · Research Grant

A Patient Reported Outcome Assessment for Patients with Early Parkinson’s Disease

Tiago A. Mestre · University of Ottawa

2026 · research · MJFF Funded Study

An AMP-PD Resource of Allele Calls for Polymorphic Determinants of Immune Function

Charlie Kim · Verily Life Sciences LLC (United States)

2026 · research · Spring 2022 RFA: Parkinson’s Pathway Molecular Data Analysis Program

Biomarker Signatures of Parkinson’s Disease Using a Novel Progression Model

Lana Chahine · University of Pittsburgh

2026 · research · ASAP CRN Discovery Fellowship 2025

The Pathogenic Role of Neuronal DNA-Sensing cGAS–STING Pathway in Alpha-Synucleinopathy

Indrani Poddar

2026 · research · ASAP CRN 2025 RFA Scientific Track

CLEAR-PD: Clearance via Lymphatics & Endocytic Alpha-Synuclein Receptors in Parkinson’s Disease

Stephen Strittmatter · Yale School Of Medicine, Department Of Neuroscience

2026 · research · Summer 2025 RFA: Personalized Approaches for Understanding, Assessing and Improving Gait in Parkinson’s Disease Research Program

Precision Mapping of Somato-Cognitive Action Network (SCAN) Pathophysiology in Parkinson’s Disease Gait Disturbance

Nico U. F. Dosenbach · Washington University in St. Louis

2026 · research · Research Grant

Cell Type Meta-eQTL Study in Human Brains

Zechuan Lin · Yale University

2026 · research · Fall 2022 RFP: Accelerating Biological Understanding and Therapeutic Translation for Parkinson’s Disease Program - Biology

Biomarker Discovery by Interrogating LRRK2 Signaling in Parkinson’s Biosamples with the Asian LRRK2 G2385R and R1628P Variants

Ai Huey Tan · University of Malaya

2026 · research · ASAP CRN 2025 RFA Scientific Track

Multi-resolution Pathway-centric Biomarker Discovery for Parkinson’s Disease Diagnosis, Prognosis, Progression, and Treatment Recommendations

Manolis Kellis · Massachusetts Institute of Technology

2026 · research · ASAP CRN Discovery Fellowship 2025